110 Computational methods to monitor treatment response and toxicity in immune-checkpoint-inhibitor treated metastatic melanoma using methylated cell-free DNA
Objectives/Goals: Immune checkpoint inhibitors (IO) have dramatically improved survival outcomes in patients with metastatic melanoma.Still, many patients do not respond these treatments, and others may experience harmful adverse events (irAEs).Thus, there Fiber an unmet need for biomarkers for real-time monitoring and management of patients expose